News

Why Recursion Pharmaceuticals Stock Tanked on Tuesday
It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.
Recursion outlines $100M partnership inflows target by end of 2026 as cash runway extends through Q4 2027
Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...
EurekAlert!5d
Connect and corrupt: C++ coroutines prone to code-reuse attack despite CFI
A code-reuse attack named Coroutine Frame-Oriented Programming (CFOP) is capable of exploiting C++ coroutines across three ...
Tech Xplore on MSN6d
C++ coroutines prone to code-reuse attack despite control flow integrity
A code-reuse attack named coroutine frame-oriented programming (CFOP) is capable of exploiting C++ coroutines across three ...